Paychex Inc: Form 10-Q for the period ended Nov 30, 2023
Filed with the SEC on Dec 21, 2023 and accepted by EDGAR at Dec 21, 2023, 16:05 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-11-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-09-01 to 2023-11-30 | $1.23bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2023-06-01 to 2023-11-30 | $2.48bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-09-01 to 2023-11-30 | $364.1m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2023-06-01 to 2023-11-30 | $724.3m | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months2023-09-01 to 2023-11-30 | $387.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2023-06-01 to 2023-11-30 | $777.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-09-01 to 2023-11-30 | $506.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-06-01 to 2023-11-30 | $1.04bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-09-01 to 2023-11-30 | $8.5m | us-gaap:InterestExpense |
| Interest expense | 6 months2023-06-01 to 2023-11-30 | $17.9m | us-gaap:InterestExpense |
| Income tax | 3 months2023-09-01 to 2023-11-30 | $125.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-06-01 to 2023-11-30 | $255.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-09-01 to 2023-11-30 | $392.7m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Diluted EPS | 3 months2023-09-01 to 2023-11-30 | $1.08 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-06-01 to 2023-11-30 | $2.24 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-09-01 to 2023-11-30 | $1.09 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-06-01 to 2023-11-30 | $2.25 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-09-01 to 2023-11-30 | 362,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-06-01 to 2023-11-30 | 362,400,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-06-01 to 2023-11-30 | $1.00bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2023-06-01 to 2023-11-30 | $79.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2023-06-01 to 2023-11-30 | $642.1m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2023-06-01 to 2023-11-30 | $169.2m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-11-30 | $1.36bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-11-30 | $8.92bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-11-30 | $12.05bn | us-gaap:Assets |
| Current liabilities | At period end2023-11-30 | $7.25bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-11-30 | $8.53bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-11-30 | $798.4m | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2023-11-30 | $13.6m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2023-11-30 | $3.52bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2023-11-30 | 359,821,826 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000950170-23-072195. Last ingested by Listed: Oct 27, 2026, 16:32 ET. Listed shows no prices and gives no investment advice.